A B S T R A C T The purpose of the present study was to investigate the nature of the vagal inhibitory innervation to the lower esophageal sphincter in the anesthetized opossum. Sphincter relaxation with electrical stimulation of the vagus was not antagonized by atropine, propranolol, phentolamine, or by catecholamine depletion with reserpine. A combination of atropine and propranolol was also ineffective, suggesting that the vagal inhibitory influences may be mediated by the noncholinergic, nonadrenergic neurons. To determine whether a synaptic link with nicotinic transmission was present, we investigated the effect of hexamethonium on vagal-stimulated lower esophageal sphincter relaxation. Hexamethonium in doses that completely antagonized the sphincter relaxation in response to a ganglionic stimulant, 1,1-dimethyl-4-phenylpiperazinium iodide (DMPP), did not block the sphincter relaxation in response to vagal stimulation at 10 pulses per second, an optimal frequency of stimulation. A combination of hexamethonium and catecholamine depletion was also ineffective, but hexamethonium plus atropine markedly antagonized sphincter relaxation (P < 0.001). Moreover, 4-(m-chlorophenyl carbamoyloxy) -2-butyltrimethylammonium chloride (McN-A-343 ), a muscarinic ganglionic stimulant, also caused relaxation of the lower esophageal sphincter. We suggest from these results that: (a) the vagal inhibitory pathway to the sphincter consists of preganglionic fibers which synapse with postganglionic neurons: (b) the synaptic transmission is predominantly cholinergic and utilizes nicotinic as well as muscarinic receptors on the postganglionic neuron, and; (c) postganglionic neurons exert their influence on the sphincter by an unidentified inhibitory transmitter that is neither adrenergic nor cholinergic.
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INTRODUCTION
The nature of the vagal inhibitory pathway to the lower esophageal sphincter (LES)1 (1) is not well defined (2, 3). Conventionally, it is believed that the vagi carry preganglionic fibers (3, 4) which synapse with the postganglionic neurons that are located in the intramural plexuses. The preganglionic fibers are thought to exert their effect by the nicotinic actions of acetylcholine (3, 4) . There are three possibilities regarding the nature of postganglionic neurons: (a) They exert their influence by the muscarinic actions of acetylcholine. It is thought that although muscarinic receptors on most smooth muscles are excitatory, the sphincter muscle may possess muscarinic receptors which are inhibitory (4) (5) (6) (7) . (b) They exert their influence by the beta-adrenergic receptors on the sphincter muscle (8) (9) (10) . (c) They exert their influence by releasing an unknown inhibitory transmitter (11) (12) (13) (14) which is neither adrenergic (11) nor cholinergic (12, 13) .
The purpose of the present investigation was to examine the nature of the vagal inhibitory pathway to LES in the anesthetized opossum by studying the influence of different antagonists of the autonomic neurotransmitters on the sphincter response to electrical stimulation of the vagus nerve.
METHODS
Studies were performed in 46 opossums (Didelphis virginiana). In this species, the LES, like that in man, is composed of smooth muscle fibers (15) . The animals were of either sex and weighed from 2 to 5 kg. They were fasted for 12-16 h before the study and they were anesthetized with sodium pentobarbital. The LES pressures were recorded with an open tip, continuously perfused catheter system, as described previously (16 Drugs were administered via an intravenous cannula, which was secured in place in one of the systemic veins. Normal saline (2 ml) was used to flush the cannula after each drug administration. Some drugs were administered intra-arterially through a cannula in the esophageal branch of the left gastric artery as described previously (16 Separate controls were run for each study because we found considerable variation in the basal sphincter pressure in different animals. The LES relaxation with vagal stimulation was measured in the same animals before and after treatment with the different antagonists. As a rule, only one antagonist or a single combination of antagonists was used in one animal. The doses of the antagonists were so chosen that they antagonized the maximally effective doses of their respective agonists at 30 min after the administration of the antagonists. 30 pg/kg atropine antagonized the effect of 20 pug/kg bethanechol; 1 mg/kg propranolol antagonized the effect of 2.5 pug/kg isoproterenol; 1 mg/kg phentolamine antagonized the effect of 50 pug/kg phenylephrine.
Catecholamine depletion was done with two doses of 3 mg/kg reserpine injected intraperitoneally at 48 and 24 h before the study. The animals reserpinized in this way appeared lethargic, had droopy eyelids, diarrhea, and subnormal temperature, and showed penile erection. The effectiveness of catecholamine depletion was tested with tyramine which acts to release catecholamines from the adrenergic nerves (17) . In the nonresperpinized animals, tyramine caused an increase in LES pressure (18 
RESULTS
Influence of cholinergic and adrenergic antagonists on the vagal-stimulated LES relaxation Influence of atropine. As summarized in Table I, 30 ug/kg atropine produced some inhibition of sphincter relaxation with vagal stimulation, but this was not statistically significant (P > 0.05). A very large dose of atropine (1,500 sg/kg), however, caused a significant decrease in the percentage fall in the sphincter pressure with vagal stimulation from 92.3±1.5 to 43.7±3.5% (P < 0.001).
Influence of adrenergic antagonists. These results are also summarized in Table I . Propranolol as well as phentolamine pretreatments were ineffective in antagonizing vagal-stimulated sphincter relaxation. Moreover, catecholamine depletion with reserpine also failed to produce a significant influence on the vagal inhibitory response (P > 0.7). A combination of propranolol and a small dose of atropine was also ineffective (P > 0.8).
Effect of DMPP on LES pressure
A nicotinic stimulant, DMPP, caused a dose-dependent fall in the LES pressure (Table II) . The maximal Influence of hexamethonium plus catecholamine depletion on vagal effects on the LES As shown in Table IV , hexamethonium administration in animals pretreated with reserpine to deplete them of catecholamine stores (17) did not antagonize LES relaxation. With vagal stimulation at 10 PPS, the LES pressure fell by 90.2±1.6% after hexamethonium plus catecholamine depletion which was not statistically different from the control value (P > 0.05).
Influence of hexamethonium plus atropine on vagal-stimulated LES relaxation
Influence of the bolus doses on vagal stimulation at 10 PPS. As shown in Table IV, administration of 20 mg/kg hexamethonium plus 30 Ag/kg atropine significantly reduced the vagal-stimulated fall in sphincter pressure from 76.5±3.6% during the control period to 9.4±2.5% after the treatment (P <0.001). The final (residual) sphincter pressure with vagal stimulation was also modified by this combination (P < 0.001).
Influence of hexamethonium infusion (40 mg/kg-h) plus atropine (30 lzg/kg) on the sphincter response with different frequencies of vagal stimulation. Fig. 1 (Table V) . Intra-arterial injection of DMPP and nicotine also cause LES relaxation (unpublished observations).
To determine the site of inhibitory action of McN-A-343 on LES, we studied the influence of intravenous tetrodotoxin. Tetrodotoxin is a neurotoxin which acts to block conduction of impulses in nerve fibers (20, 21 The effect of McN-A-343 was not antagonized by hexamethonium. McN-A-343 caused 66.4±4.9% fall in the sphincter pressure (n = 3) after 20 mg/kg hexamethonium, which antagonized the inhibitory effect of the nicotinic stimulant, DMPP. The reduction in sphinc-FIGURE 2 Schematic representation of the major vagal inhibitory pathway to the LES. The vagi carry preganglionic neurons which synapse with postganglionic inhibitory neurons. The synaptic transmission involves both nicotinic and muscarinic transmission. Both of these pathways of synaptic transmission are substantial, and only when both of these pathways are blocked, antagonism of synaptic transmission becomes obvious, particularly at the higher frequencies of stimulation. The nicotinic and muscarinic receptors may be present on different or same postganglionic neurons but, as shown in this model, we consider the latter possibility more likely. The postganglionic inhibitory neurons are neither adrenergic nor cholinergic; their neurotransmitter is not known at present.
ter pressure caused by intra-arterial McN-A-343 after hexamethonium treatment was not significantly different from the control value (P < 0.5). These observations further indicate that McN-A-343 did not exert its inhibitory influence by the nicotinic receptors. However, in two animals, during DMPP tachyphylaxis, the inhibitory effect of McN-A-343 on the LES was antagonized.
DISCUSSION
The results of these studies are best explained by the model outlined in Fig. 2 . The major component of the vagal inhibitory pathway to the LES consists of preganglionic fibers which are cholinergic, and the acetylcholine released by them exerts its influence upon the postganglionic inhibitory neurons through both nicotinic and muscarinic pathways. The postganglionic neurons are neither adrenergic nor cholinergic, and they act by releasing a currently unknown neurotransmitter which acts to inhibit the LES.
The presence of a muscarinic pathway in the parasympathetic ganglia of the gut has not been demonstrated before (19, 22) , although several studies in the sympathetic ganglia have shown the existence of such a transmission (23) (24) (25) (26) . The muscarinic and nicotinic transmission in the vagal pathway cannot be differentiated on the basis of the frequency of stimulation because atropine as reported elsewhere (1) As regards the nature of the postganglionic inhibitory neurons, three possibilities need consideration as follows: First, the conventional view which is currently cited in the textbooks (3, 4) is that they are cholinergic and exert their influence by muscarinic receptors which act to inhibit certain effector organs such as cardiac conduction system and many regions in the central nervous system (4, 25) . These inhibitory effects of acetylcholine are due to a hyperpolarizing effect and may be shown even by the cells which are predominantly excited by it. However, all these inhibitory effects are exclusively muscarinic as they are blocked by small doses of atropine (25) . We found, as previously observed (2, 5, 6) , that atropine, even in a dose which is over 50 times larger than the antimuscarinic dose, was not able to completely block the vagal response. Yet a small dose of atropine in combination with hexamethonium was able to markedly antagonize the vagalstimulated sphincter relaxation. Moreover, our studies with McN-A-343 suggest that the muscarinic receptors which participate in transmission of inhibitory influence of the vagus on the LES lie at the synaptic site between the pre-and postganglionic neurons rather than on the sphincter muscle as the fall in sphincter pressure caused by McN-A-343 was abolished by the blockade of axonal transmission by tetrodotoxin. These observations are consistent with the view that sphincter muscles do not possess inhibitory muscarinic receptors (22, 33) . The effect of a large dose of atropine can be explained on the basis of its nonspecific inhibitory influence on synaptic transmission (4) . Second, they may be adrenergic neurons which may exert their effect directly on the sphincter muscle by the beta-adrenergic receptors (6, 9, 10, 34), or they may be adrenergic interneurons (35) and exert their influence by inhibiting any excitatory neurons. Our studies show that vagal inhibitory responses were not antagonized by either alpha or beta blockade or by catecholamine depletion with reserpine, suggesing that adrenergic inhibitory pathways are not involved in the vagal-stimulated sphincter relaxation.
Third, they may belong to the family of newly described inhibitory neurons which are neither adrenergic nor cholinergic; their neurotransmitter is not known at present. Burnstock has suggested that ATP or a related nucleotide may be the transmitter, and he has named them as purinergic neurons (14) . Presence of nonadrenergic, noncholinergic neurons in the LES has recently been suggested (11) (12) (13) . Our results are consistent with the view that the postganglionic inhibitory neurons in the vagal pathway to the LES are neither adrenergic nor cholinergic.
The results of our studies may be of considerable physiological and clinical importance, as outlined below:
First, the vagus nerve-LES preparation may provide a model for further studies on synaptic transmission in the inhibitory parasympathetic pathways to the gut. This is because the vagus carries only inhibitory influences to the LES, whereas to most other organs it carries both inhibitory and excitatory influences. Moreover, because of background tonic contraction of the LES, the inhibitory responses to vagal stimulation are easily studied and quantitated. For example, in the previous studies on the nature of synaptic transmission in the vagal inhibitory pathway to organs other than LES, the presence of muscarinic transmission may have been totally overlooked because the tissues and organs had to be pretreated with atropine to reveal the inhibitory action of vagal stimulation (29) (30) (31) . Second, the model presented here may explain, at least in part, the possible reasons for conflicting reports of cholinergic agents on the LES (7). This model suggests that cholinergic agents may act indirectly via the intramural inhibitory neuron to cause sphincter relaxation in addition to their direct action on the sphincter muscle which is to cause its contraction. The observed response with any of these agents would be the algebraic sum of their direct and indirect effects. The reported sphincter relaxation with acetylcholine may be due to its indirect action via the inhibitory neurons, which led some observers to postulate the presence of inhibitory muscarinic receptors on the sphincter muscle (4) (5) (6) 36) .
Third, several morphologic studies have demonstrated that patients with achalasia show lesions in the neurons of Auerbach's plexus (37) . These neurons are usually considered to be cholinergic and excitatory. This concept does not satisfactorily explain the abnormality in the LES relaxation which is the primary functional abnormality of the sphincter in achalasia. If a parallel can be drawn from our studies in the opossum, it can be assumed that the intramural neurons which show degeneration are inhibitory in nature. Therefore, lesions in this pathway may cause impairment in LES relaxation. This model would also suggest that the degeneration of the inhibitory neurons may lead to enhanced contraction of the LES with cholinemimetic agents (38) in patients with achalasia due to the loss of the indirect (via the neurons) inhibitory effect of cholinergic agents on the sphincter, leaving their direct stimulatory action on the sphincter muscle unopposed.
